Bloomberg Business: The FDA Recall System is Voluntary and Broken
Bloomberg Business recently published a comprehensive look at how patients suffer when drug manufacturers and regulators fail to protect them and effectively recall dangerous drugs from their medicine cabinets. For the past 25 years, the experienced drug injury lawyers at Cory Watson have helped thousands of victims hurt because of...
Continue ReadingCory Watson Leads Charge on Opioid Litigation Battle in Arkansas
Arkansas Counties and Cities File Joint Lawsuit Against Opioid Drug Manufacturers Cory Watson Attorneys is leading the charge on groundbreaking opioid litigation, working with county, city and state officials to represent the people of Arkansas in the fight against the opioid epidemic. In an unprecedented approach, hundreds of county, city,...
Continue ReadingWhat You Need to Know About Opioid Drug Lawsuits
Opioid use in the United States has reached epidemic levels. Opioids are highly addictive and dangerous, but have been increasingly prescribed over the past two decades. In July 2017, President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis declared that opioids were killing roughly 142 people in the...
Continue ReadingHeartburn Medication Linked to Kidney Failure
Nexium, Prevacid, Prilosec, Protonix, AciPhex and Zegerid are in a class of drugs called Proton Pump Inhibitors (PPIs) that are widely prescribed to treat heartburn, acid reflux and gastroesophageal reflux disease (GERD) in millions of Americans. These common medications are available over-the-counter or by prescription. Research published in the Journal of...
Continue ReadingPopular Heartburn Medications Linked to Kidney Injury
More than 15 million Americans currently rely on proton pump inhibitor (PPI) drugs to relieve heartburn and acid reflux caused by excessive acid produced by the stomach. Stomach acid can cause irritation in patients, and PPI drugs aim to reduce production of stomach acid to reduce irritation. PPIs are the...
Continue ReadingZofran Linked to Potential Birth Defects
Zofran (generic name: ondansetron) is a popular anti-nausea prescription drug, approved by the US Food and Drug Administration (FDA) for treatment of nausea and vomiting in cancer patients after surgery. The drug is manufactured by GlaxoSmithKline (GSK), a large pharmaceutical company based in the United Kingdom. While Zofran is only...
Continue ReadingFDA Delays Rule on Generic Drug Labels Until 2017
The Food and Drug Administration (FDA) has again delayed a decision on whether generic drug makers will be held responsible for warning patients about the risks of their medications. This comes as a disappointment to trial lawyers and consumer groups who want to eliminate the legal loophole which prevents patients...
Continue ReadingFDA Investigating Invokana Amputation Problems
The FDA released a safety announcement alerting the public to a new study that found an increase in leg and foot amputations in patients who used Invokana (canagliflozin) to treat type 2 diabetes. This warning comes on the heels of several other FDA warnings regarding the drug such as diabetic...
Continue ReadingFDA Issues New Abilify® Warning
Cory Watson Attorneys is no longer accepting these cases. The Food and Drug Administration (FDA) issued a new warning on May 3 that links the use of Aripiprazole (Abilify, Abilify Maintena, Aristada) with compulsive or uncontrollable urges such as binge eating, excessive shopping, gambling, and an increase in sex drive....
Continue ReadingThe Secret Lives of Pharmaceutical Companies
Many companies engage in less-than-honest practices, but it is even more concerning when the companies that make your medications aren’t telling you the whole truth. A third of clinical trials performed by pharmaceutical companies and reviewed by the U.S. Food and Drug Administration (FDA) for approval were not made available...
Continue Reading